End-of-day quote
Shanghai S.E.
03:30:00 11/07/2024 am IST
|
5-day change
|
1st Jan Change
|
31.42
CNY
|
+4.98%
|
|
+3.70%
|
-20.74%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
26,000
|
23,347
|
16,679
|
13,221
|
-
|
-
|
Enterprise Value (EV)
1 |
26,000
|
23,347
|
16,679
|
13,221
|
13,221
|
13,221
|
P/E ratio
|
39
x
|
18.6
x
|
31.7
x
|
16
x
|
13.1
x
|
10.1
x
|
Yield
|
0.48%
|
0.64%
|
1.77%
|
1.59%
|
1.54%
|
1.59%
|
Capitalization / Revenue
|
1.67
x
|
0.81
x
|
0.96
x
|
0.68
x
|
0.63
x
|
0.5
x
|
EV / Revenue
|
1.67
x
|
0.81
x
|
0.96
x
|
0.68
x
|
0.63
x
|
0.5
x
|
EV / EBITDA
|
-
|
15.1
x
|
18.1
x
|
9.63
x
|
7.94
x
|
6.48
x
|
EV / FCF
|
-209
x
|
-10.6
x
|
11.6
x
|
57.7
x
|
-12.1
x
|
-
|
FCF Yield
|
-0.48%
|
-9.47%
|
8.6%
|
1.73%
|
-8.3%
|
-
|
Price to Book
|
6.96
x
|
2.85
x
|
1.94
x
|
1.44
x
|
1.31
x
|
1.2
x
|
Nbr of stocks (in thousands)
|
3,52,201
|
4,20,771
|
4,20,771
|
4,20,771
|
-
|
-
|
Reference price
2 |
73.82
|
55.49
|
39.64
|
31.42
|
31.42
|
31.42
|
Announcement Date
|
25/01/22
|
19/01/23
|
17/01/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
15,566
|
28,751
|
17,311
|
19,309
|
21,116
|
26,331
|
EBITDA
1 |
-
|
-
|
1,542
|
922.5
|
1,373
|
1,665
|
2,042
|
EBIT
1 |
-
|
617.5
|
1,240
|
560.4
|
882.2
|
1,089
|
1,402
|
Operating Margin
|
-
|
3.97%
|
4.31%
|
3.24%
|
4.57%
|
5.16%
|
5.33%
|
Earnings before Tax (EBT)
1 |
-
|
612.9
|
1,241
|
558.6
|
882.5
|
1,088
|
1,402
|
Net income
1 |
250.5
|
555.3
|
1,121
|
527.5
|
826.1
|
1,007
|
1,307
|
Net margin
|
-
|
3.57%
|
3.9%
|
3.05%
|
4.28%
|
4.77%
|
4.96%
|
EPS
2 |
0.9714
|
1.893
|
2.986
|
1.250
|
1.965
|
2.390
|
3.107
|
Free Cash Flow
1 |
-
|
-124.2
|
-2,212
|
1,435
|
229
|
-1,097
|
-
|
FCF margin
|
-
|
-0.8%
|
-7.69%
|
8.29%
|
1.19%
|
-5.2%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
155.55%
|
16.68%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
272.05%
|
27.72%
|
-
|
-
|
Dividend per Share
2 |
-
|
0.3571
|
0.3571
|
0.7000
|
0.5000
|
0.4850
|
0.5000
|
Announcement Date
|
18/07/21
|
25/01/22
|
19/01/23
|
17/01/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-124
|
-2,212
|
1,435
|
229
|
-1,097
|
-
|
ROE (net income / shareholders' equity)
|
-
|
18.7%
|
20.9%
|
6.3%
|
9.01%
|
10.2%
|
12%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
3.65%
|
4.79%
|
5.94%
|
7.73%
|
Assets
1 |
-
|
-
|
-
|
14,432
|
17,246
|
16,953
|
16,904
|
Book Value Per Share
2 |
-
|
10.60
|
19.50
|
20.40
|
21.80
|
24.00
|
26.30
|
Cash Flow per Share
2 |
-
|
-
|
-3.710
|
6.130
|
2.760
|
3.390
|
3.070
|
Capex
1 |
-
|
556
|
651
|
1,145
|
1,254
|
1,274
|
397
|
Capex / Sales
|
-
|
3.57%
|
2.26%
|
6.62%
|
6.49%
|
6.03%
|
1.51%
|
Announcement Date
|
18/07/21
|
25/01/22
|
19/01/23
|
17/01/24
|
-
|
-
|
-
|
Last Close Price
31.42
CNY Average target price
38.47
CNY Spread / Average Target +22.44% Consensus |
1st Jan change
|
Capi.
|
---|
| -20.74% | 182.15Cr | | +23.27% | 6.98TCr | | -3.47% | 4.71TCr | | +24.97% | 4.5TCr | | +34.90% | 2.97TCr | | +9.40% | 2.02TCr | | +15.06% | 1.74TCr | | -10.41% | 1.52TCr | | -24.93% | 1.52TCr | | -29.33% | 1.22TCr |
Other Specialty Chemicals
|